TSH and prolactin secretions in Hashimoto's thyroiditis following withdrawal of thyroid hormone therapy.

Changes in the pituitary-thyroid axis in patients with Hashimoto's thyroiditis following withdrawal of thyroid suppressive therapy were analyzed. The group of patients with thyroid adenoma served as control (group I). Patients with Hashimoto's thyroiditis were divided into 2 groups on the basis of serum TSH levels 8 weeks after discontinuing the exogenous thyroid hormone (group II, less than 10 microunits/ml; group III, more than 10 microunits/ml). During treatment with L-T4(200 micrograms/day) or L-T3(50 micrograms/day), there was no significant difference in serum T4-I and T3 levels among the three groups. Following L-T4 withdrawal, basal serum TSH levels were higher at 2 to 8 weeks in groups II and III than in group I. Serum TSH response to TRH was greater at 4 to 8 weeks in groups II and III than in group I. Following L-T3 withdrawal, basal serum TSH levels were higher at 1 and 2 weeks in group II than in group I, while those of group III were consistently higher during the study. Higher TSH responses to TRH were observed at 1 to 8 weeks in groups II and III. Neither basal nor TRH-induced prolactin (PRL) secretion differed significantly among the three groups. We have demonstrated that pituitary TSH secretion in patients with Hashimoto's thyroiditis is affected more by withdrawal of thyroid hormone therapy than in patients with thyroid adenoma. In addition, the present findings suggest a difference between the sensitivity of thyrotrophs and lactotrophs in Hashimoto's thyroiditis after prolonged thyroid therapy is discontinued.

[1]  Y. Shimomura,et al.  Clofibrate and a related compound suppress TSH secretion in primary hypothyroidism. , 1980, Acta Endocrinologica.

[2]  F. Azizi,et al.  Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy. , 1975, The New England journal of medicine.

[3]  H. Nakabayashi,et al.  Clinical value of the thyrotropin-releasing hormone stimulation test in predicting mild hypothyroid state in chronic thyroiditis. , 1975, Endokrinologie.

[4]  J. Hershman,et al.  Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy. , 1975, The Journal of clinical endocrinology and metabolism.

[5]  T. Yamaji.  Modulation of prolactin release by altered levels of thyroid hormones. , 1974, Metabolism: clinical and experimental.

[6]  B. Rapoport,et al.  Interrelationships in the regulation of TSH and prolactin secretion in man: effects of L-dopa, TRH and thyroid hormone in various combinations. , 1974, The Journal of clinical endocrinology and metabolism.

[7]  R. Pelkonen,et al.  Serum thyrotrophin and the response to thyrotrophin releasing hormone in symptomless autoimmune thyroiditis and in borderline and overt hypothyroidism. , 1974, Acta endocrinologica.

[8]  A. Frantz,et al.  Prolactin stimulation by thyrotropin-releasing hormone in a patient with isolated thyrotropin deficiency. , 1972, The New England journal of medicine.

[9]  J. Wilber,et al.  Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man. , 1971, The Journal of clinical endocrinology and metabolism.

[10]  H. Gharib,et al.  Radioimmunoassay for human thyrotrophin. Clinical value in patients with normal and abnormal thyroid function. , 1971, Annals of internal medicine.

[11]  P. Czernichow,et al.  Juvenile chronic lymphocytic thyroiditis: clinical, laboratory and histological correlations. , 1970, The Journal of clinical endocrinology and metabolism.